Emily Ferris and Alex Arbuckle describe how using mint Lesion™ has enhanced their clinical trial operations, enabling “a more cooperative approach between [their] radiologists and oncologists” while simultaneously saving time and reducing costs.
Faced with a multitude of clinical trial site reads each day, Ms. Ferris and Mr. Arbuckle explain how they benefit from a more efficient workflow by using a dedicated software platform which provides a comprehensive and compliant response assessment and supports them in maintaining oversight of clinical trial imaging analysis design.
Ms. Ferris is a Lead Image Analyst and Mr. Arbuckle is a Clinical Research Imaging Core Manager at the University of Wisconsin Carbone Cancer Center.
Enhancing flexibility and communication while saving costs and time in clinical trials
Related Resources
Related Resources
ESOI/EORTC Workshop in Barcelona: Participants practice tumour response assessment using mint Lesion™
The autumn workshop of the European Society of Oncological Imaging (ESOI) and the European Organisation for Research and Treatment of Cancer (EORTC)…
Mint Medical showcases MSK-Prototype at IMR 2017 in Hamburg
Mint Medical was one of the sponsors of the first Intensive course Musculoskeletal Radiology (IMR) which took place on September 8th and 9th 2017 in…
A look ahead with mint Lesion 3.3
Mint Medical is pleased to announce the recent release of their software product version 3.3 of mint Lesion™ which was completed during recent weeks.…